Equities

Techno Medica Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
6678:TYO

Techno Medica Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)2,568.00
  • Today's Change-18.00 / -0.70%
  • Shares traded9.80k
  • 1 Year change+45.58%
  • Beta0.1996
Data delayed at least 15 minutes, as of Feb 13 2026 06:30 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Techno Medica Co., Ltd. is a Japan-based company mainly engaged in development, manufacture, sale and export of analysis device for clinical examination equipment and other medical equipment, as well as devices repair services. The blood collection tube preparation apparatus business provides blood collection peripheral equipment, such as blood and urine collection automation reception equipment, among others, as well as blood tube preparation systems. The laboratory test apparatus business provides blood gas analysis apparatus, electrolyte analyzers, erythrocyte sedimetation rate measuring machines, among others. The consumable goods business provides blood collecting tubes, labels, sensor cards, calibration packs, among others, as well as maintenance services.

  • Revenue in JPY (TTM)10.70bn
  • Net income in JPY1.04bn
  • Incorporated1987
  • Employees244.00
  • Location
    Techno Medica Co Ltd5-5-1, Nakamachidai, Tsuzuki-kuYOKOHAMA-SHI 224-0041JapanJPN
  • Phone+81 459481961
  • Fax+81 459481962
  • Websitehttps://www.technomedica.co.jp/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Japan Medical Dynamic Marketing Inc24.58bn-1.05bn13.05bn538.00--0.517124.170.5309-40.02-40.02933.26953.320.72020.63684.3445,695,190.00-3.134.27-3.804.9459.9365.20-4.355.781.2812.480.180228.508.356.79-136.31---1.378.45
DVx Inc55.33bn308.75m13.19bn334.0041.541.4712.210.238529.4629.465,278.63831.732.2417.684.12165,663,400.001.252.643.286.459.6011.080.5581.281.23--0.002563.099.752.42137.18-12.33-2.4315.81
OLBA Healthcare Holdings Inc124.48bn1.43bn13.22bn1.39k8.771.056.330.1062241.07241.0721,003.792,008.322.7716.234.8089,362,800.003.173.439.9111.3911.2611.491.151.220.958266.630.225530.513.492.61-4.6834.3828.7114.87
Daiken Medical Co Ltd10.17bn981.12m15.28bn180.0014.051.7912.441.5034.1534.15353.89267.890.90354.563.6456,482,360.008.727.8611.8311.2538.7941.239.659.511.89183.100.193969.412.073.1511.035.01-0.18892.83
Seed Co Ltd33.57bn1.17bn15.86bn985.0013.520.85373.570.472538.7638.761,109.07613.830.642.357.4334,078,080.002.222.313.583.9445.1242.203.473.300.59286.620.575736.012.580.8892-44.3833.9912.644.56
Hoshi Iryo-Sanki Co Ltd15.45bn1.45bn17.24bn500.0010.870.815710.461.12463.58463.584,949.106,178.920.626224.075.8130,904,100.005.886.007.197.6149.7248.989.399.193.09--0.0015.312.196.784.2114.77-18.276.96
Medius Holdings Co Ltd295.20bn1.36bn18.59bn2.61k13.740.91694.890.06360.8660.8613,250.33911.802.3918.174.56112,928,700.001.101.654.356.0311.8212.070.45960.64920.924313.810.587328.5711.126.5322.307.6516.287.39
Techno Medica Co Ltd10.70bn1.04bn22.50bn244.0017.151.2419.812.10149.78149.781,542.982,077.510.64062.173.6943,841,880.006.226.587.167.7947.6849.669.7112.305.99--0.0040.22-3.680.1936-25.480.0825-40.566.77
Findex Inc5.90bn1.18bn23.63bn311.0019.144.1515.704.0046.3946.39232.45214.020.94678.734.9918,984,330.0019.2116.4821.5419.1963.7758.1820.2916.354.18--0.0034.7312.516.419.7518.41-4.0213.40
Japan Tissue Engineering Co., Ltd.2.26bn-461.45m24.41bn204.00--4.63--10.81-11.36-11.3655.62129.740.36614.015.6311,071,850.00-7.48-4.87-8.33-5.5159.6259.41-20.43-15.896.59--0.00---2.341.23-278.32--0.5717--
Kusurinomadoguchi Inc11.71bn2.59bn29.26bn484.0011.282.929.102.50228.38228.381,033.34882.360.6939--3.1924,186,230.0015.71--26.98--56.02--22.65------0.158--28.41--133.66------
Data as of Feb 13 2026. Currency figures normalised to Techno Medica Co Ltd's reporting currency: Japanese Yen JPY

Institutional shareholders

9.50%Per cent of shares held by top holders
HolderShares% Held
Fidelity Management & Research Co. LLCas of 31 Dec 2025420.81k4.80%
Nomura Asset Management Co., Ltd.as of 08 Jan 2026121.40k1.39%
Fidelity Investments Canada ULCas of 30 Nov 202590.00k1.03%
Amova Asset Management Co., Ltd.as of 09 Jan 202657.40k0.66%
Daiwa Asset Management Co. Ltd.as of 30 Dec 202554.50k0.62%
Dimensional Fund Advisors LPas of 30 Nov 202541.00k0.47%
Mitsubishi UFJ Asset Management Co., Ltd.as of 08 Jan 202625.30k0.29%
Dimensional Fund Advisors Ltd.as of 30 Nov 20257.80k0.09%
BlackRock Japan Co. Ltd.as of 08 Jan 20267.80k0.09%
Asset Management One Co., Ltd.as of 08 Jan 20266.10k0.07%
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.